Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Bar plots of age-standardized (world population) death rates per 100 000 persons for the year 2014 (blue, ... Figure 1. Bar plots of age-standardized.

Published byMorgan Clark Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1. Bar plots of age-standardized (world population) death rates per 100 000 persons for the year 2014 (blue, ... Figure 1. Bar plots of age-standardized."— Presentation transcript:

1 Figure 1. Bar plots of age-standardized (world population) death rates per 100 000 persons for the year 2014 (blue, ... Figure 1. Bar plots of age-standardized (world population) death rates per 100 000 persons for the year 2014 (blue, dark grey) and predicted rates for 2019 (orange, light grey) with 95% prediction intervals (PIs) for total cancer and the 10 major cancer sites in EU men and women. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Ann Oncol, mdz051, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 2. Age-standardized (world population) cancer mortality rate trends in quinquennia from 1970–1974 to 2010– Figure 2. Age-standardized (world population) cancer mortality rate trends in quinquennia from 1970–1974 to 2010–2014 and predicted rates for 2019 with 95% prediction intervals (PIs), for all neoplasms and both sexes (left) and each cancer site under study for men (centre) and women (right), in the EU. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Ann Oncol, mdz051, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Figure 3. Age-standardized (world population) cancer mortality rate trends for women in quinquennia from 1970–1974 to ... Figure 3. Age-standardized (world population) cancer mortality rate trends for women in quinquennia from 1970–1974 to 2010–2014 and predicted rates for 2019 with 95% PIs for breast cancer in studied countries and in the EU as a whole. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Ann Oncol, mdz051, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 4. Annual breast cancer age-standardized (world population) death rates in the EU per 100 000 for all ages, ... Figure 4. Annual breast cancer age-standardized (world population) death rates in the EU per 100 000 for all ages, 20–49, 50–69 and 70–79 age groups from 1970 to 2014, the resulting joinpoint regression models and predicted rates for the year 2019 with 95% PIs. On the left, all ages (full circles) and 20–49 (empty circles) age groups; on the right, 50–69 (full circles) and 70–79 (empty circles) age groups. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Ann Oncol, mdz051, The content of this slide may be subject to copyright: please see the slide notes for details.

5 Figure 5. Total avoided cancer deaths for EU men and women between the top rate in 1988 and 2019 (gold, light grey ... Figure 5. Total avoided cancer deaths for EU men and women between the top rate in 1988 and 2019 (gold, light grey area); observed numbers of cancer deaths from 1970 to 2014 and predicted cancer deaths from 2015 to 2019 (blue, dark grey line); estimated numbers of total cancer deaths by applying 1988 age-specific peak mortality rate (orange, light grey line). During the 31 years period, 5 290 000 cancer deaths have been avoided (3 517 000 in men and 1 773 000 in women). In 2019 alone are predicted to be avoided 237 000 in men and 122 000 in women, for a total of 359 000. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Ann Oncol, mdz051, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 1. Bar plots of age-standardized (world population) death rates per 100 000 persons for the year 2014 (blue, ... Figure 1. Bar plots of age-standardized."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Multivariable-adjusted predictors of PAC

Figure 1 Multivariable-adjusted predictors of PAC
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1. Medicaid receipt and ACA favorability

Figure 1. Medicaid receipt and ACA favorability
Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.

Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Figure 1 Comparison of MITRA-FR and COAPT trial outcomes

Figure 1 Comparison of MITRA-FR and COAPT trial outcomes
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
bDMARD: biologic DMARD.

bDMARD: biologic DMARD.
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,

Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,
Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Similar presentations

Ads by Google